Skip to content

OMEROS CORP

OMER

CIK 0001285819 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
$68.72M
−59.3% YoY Q1 May 2026
Net Income (TTM)
−$33.74M
+97.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.86
+98.1% YoY Q1 May 2026
Gross Margin
98.2%
Q1 May 2026
Operating Margin
-161.7%
Q1 May 2026
Net Margin
-49.1%
Q1 May 2026
Free Cash Flow (TTM)
$82.31M
Q1 May 2026
Cash
$1.91M
Q1 May 2026
Total Debt
$134.26M
Q1 May 2026
Shares Outstanding
72.38M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings